Abstract:Salidroside (SAL) is a phenylpropanoid glycoside isolated from the medicinal plant Rhodiola rosea. A recent study has reported that SAL can efficiently decrease atherosclerotic plaque formation in low-density lipoprotein receptor-deficient mice. This study was to investigate the molecular mechanism of antiatherogenic effects of SAL. Given the importance of endothelial nitric oxide synthase (eNOS) in atherosclerosis, we sought to elucidate whether SAL could stimulate eNOS activation and also to explore its upstream signaling pathway. Six-week old apoE−/− male mice were fed a high-fat diet for 8weeks and then were administered with SAL for another 8weeks. SAL significantly improved endothelial function associated with increasing eNOS activation, thus reduced the atherosclerotic lesion area. SAL increased eNOS-Ser1177 phosphorylation and decreased eNOS-Thr495 phosphorylation, indicative of eNOS activation in endothelium. The aortic sinus lesions in SAL treated mice displayed reduced inflammation. SAL significantly activated AMP-activated protein kinase (AMPK). Both AMPK inhibitor and AMPK small interfering RNA (siRNA) abolished SAL-induced Akt-Ser473 and eNOS-Ser1177 phosphorylation. In contrast, LY294002, the PI3k/Akt pathway inhibitor, abolished SAL-induced phosphorylation and expression of eNOS. High performance liquid chromatography (HPLC) analysis revealed that SAL decreased cellular ATP content and increased the cellular AMP/ATP ratio, which was associated with the activation of AMPK. SAL was found to decrease the mitochondrial membrane potential (ΔΨm), which is a likely consequence of reduced ATP production. The action of SAL to reduce atherosclerotic lesion formation may at least be attributed to its effect on improving endothelial function by promoting nitric oxide (NO) production, which was associated with mitochondrial depolarization and subsequent activation of the AMPK/PI3K/Akt/eNOS pathway. Taken together, our data described the effects of SAL on mitochondria, which played critical roles in improving endothelial function in atherosclerosis.

The Therapeutic Effects and Mechanisms of Salidroside on Cardiovascular and Metabolic Diseases: An Updated Review

Salidroside: A review of its recent advances in synthetic pathways and pharmacological properties

Rhodiola and Salidroside in the Treatment of Metabolic Disorders

Therapeutic potential and molecular mechanisms of salidroside in ischemic diseases

The Sources of Salidroside and Its Targeting for Multiple Chronic Diseases

Salidroside: An Overview of Its Promising Potential and Diverse Applications

Pharmacological functions of salidroside in renal diseases: facts and perspectives

Salidroside improves endothelial function and alleviates atherosclerosis by activating a mitochondria-related AMPK/PI3K/Akt/eNOS pathway

Salidroside - Can it be a Multifunctional Drug?

Progress on the Role of Salidroside in Neurodegenerative Diseases

Pharmacological Activities and Progress in Structure Modification of Salidroside

Pharmacological Effects of Salvianolic Acid B Against Oxidative Damage

Salidroside Improved Cerebrovascular Vasodilation in Streptozotocin-Induced Diabetic Rats Through Restoring the Function of BKCa Channel in Smooth Muscle Cells

Salidroside Contributes to Reducing Blood Pressure and Alleviating Cerebrovascular Contractile Activity in Diabetic Goto-Kakizaki Rats by Inhibition of L-type Calcium Channel in Smooth Muscle Cells

The Protective Effect of Salidroside on Hypoxia-Induced Corpus Cavernosum Smooth Muscle Cell Phenotypic Transformation.

Protective Effect of Salidroside on Streptozotocin-Induced Diabetic Nephropathy by Inhibiting Oxidative Stress and Inflammation in Rats Via the Akt/GSK-3β Signalling Pathway.

Metabolic Profiling Reveals That Salidroside Antagonizes Hypoxic Injury Via Modulating Energy and Lipid Metabolism in Cardiomyocytes.

The Effect of Salvianolic Acid on Vascular Protection and Possible Mechanisms

The application of proteomics and phosphoproteomics to reveal the molecular mechanism of salidroside in ameliorating myocardial hypoxia

Salidroside enhances NO bioavailability and modulates arginine metabolism to alleviate pulmonary arterial hypertension

Salidroside attenuates cardiac dysfunction in a rat model of diabetes